Phosphorylated/Activated HER2 as a Marker of Clinical...

Cancer Investigation 2005 / 01 Vol. 23; Iss. 6

Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast Cancer

Modi, Shanu, DiGiovanna, Michael P., Lu, Zhao, Moskowitz, Chaya, Panageas, Katherine S., Van Poznak, Catherine, Hudis, Clifford A., Norton, Larry, Tan, Lee, Stern, David F., Carter, Darryl, Seidman, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Journal:
Cancer Investigation
DOI:
10.1080/07357900500201301
Date:
January, 2005
File:
PDF, 847 KB
english, 2005
Conversion to is in progress
Conversion to is failed